Alltrna raises $109 million in a Series B financing to advance tRNA based therapies
- blonca9
- Aug 9, 2023
- 1 min read
CEO Michelle Werner explains the science behind how Alltrna is trying to harness transfer RNA to develop therapies for stop codon disease.